# Concord Medical Services Holdings Ltd: Form 20-F for the period ended Dec 31, 2020

- Company: [Concord Medical Services Holdings Ltd](/companies/ccm.md) (CIK 1472072)
- Form: 20-F
- Filed: 2021-10-15
- Accepted by EDGAR: Oct 15, 2021, 16:16 ET
- Period: 2020-12-31
- Accession: 0001104659-21-126753
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1472072/000110465921126753/ccm-20201231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1472072/000110465921126753/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | $26.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2020-01-01 to 2020-12-31 | $32.2m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2020-01-01 to 2020-12-31 | $2.0m | us-gaap:GrossProfit |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | −$48.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2020-01-01 to 2020-12-31 | $12.5m | us-gaap:InterestExpense |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | −$5.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | −$47.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2020-01-01 to 2020-12-31 | −$0.78 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | −$35.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | $25.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2020-12-31 | $51.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-12-31 | $103.6m | us-gaap:AssetsCurrent |
| Total assets | at 2020-12-31 | $817.6m | us-gaap:Assets |
| Current liabilities | at 2020-12-31 | $78.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-12-31 | $449.6m | us-gaap:Liabilities |
| Long-term debt | at 2020-12-31 | $301.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-12-31 | $19.1m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2020-12-31 | $3.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-12-31 | −$101.6m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2020-12-31 | 130,251,685 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1472072/000110465921126753/ccm-20201231x20f.htm

Filed Oct 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-126753. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.
